Literature DB >> 6319268

Anaplastic small cell neoplasms of the thyroid: an immunoperoxidase study.

N C Mambo, S M Irwin.   

Abstract

The cell origins of ten anaplastic small cell neoplasms of the thyroid gland were investigated using the immunoperoxidase technique. Sections of the neoplasms were examined for immunostaining for the tissue markers of B lymphocytes, thyroid follicular cells, and C cells by incubation with antisera to the lambda and kappa light chains, human thyroxine and human calcitonin, respectively. Six neoplasms were identified as malignant lymphomas, and two were identified as anaplastic small cell follicular carcinomas. The cell origins of the remaining two neoplasms could not be determined. The prognosis for patients with malignant lymphoma was favorable compared with the prognoses for patients in the other two groups. The prognosis for patients with anaplastic small cell follicular carcinomas was better than for those with small cell malignancies of undetermined cell origins. These findings suggest an important role for the immunoperoxidase technique in the precise classification of anaplastic small cell neoplasms of the thyroid.

Entities:  

Mesh:

Year:  1984        PMID: 6319268     DOI: 10.1016/s0046-8177(84)80330-5

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  Evidence of vascular differentiation in anaplastic tumours of the thyroid--an immunohistological study.

Authors:  F Eckert; U Schmid; F Gloor; C Hedinger
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

2.  Lymphoid and epithelial markers in small cell anaplastic thyroid tumours.

Authors:  A D Burt; D J Kerr; I L Brown; P Boyle
Journal:  J Clin Pathol       Date:  1985-08       Impact factor: 3.411

3.  Immunohistochemical reclassification of anaplastic carcinoma reveals small and giant cell lymphoma.

Authors:  T Hölting; P Möller; C Tschahargane; H Meybier; H Buhr; C Herfarth
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.